Search results
Results From The WOW.Com Content Network
Little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria. Although puberty blockers are known to be safe and physically reversible treatment if stopped in the short term, it is also not known whether hormone blockers affect the development of factors like bone mineral density, brain ...
While the recent decision by the NHS cites a lack of research surrounding the long-term effects of puberty blockers, the treatment has been a medically accepted practice since the late 1980s, ...
[95] [101] In addition to apparently showing effectiveness as an antiandrogen and puberty blocker, bicalutamide alone increased estradiol levels and promoted feminization as a secondary effect. [ 95 ] [ 101 ] This included breast development to Tanner stages 2 to 5 in 85% of the patients at the first follow-up visit at 6.3 months of treatment.
There are ongoing, long-term studies of puberty blockers for transgender youth, Wilson said. “Medications always have risks and benefits,” she added, “and good decision-making is based on ...
It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers. In respect of young persons aged 16 and over, the legal position is that there is a presumption that they have the ability to consent to medical treatment.
The case was brought by Keira Bell – a 24-year-old woman who began taking puberty blockers when she was 16, before later “detransitioning” – and the mother of a teenager who is on the ...
Foot and ankle surgery is a sub-specialty of orthopedics and podiatry that deals with the treatment, diagnosis and prevention of disorders of the foot and ankle. Orthopaedic surgeons are medically qualified, having been through four years of college, followed by 4 years of medical school or osteopathic medical school to obtain an M.D. or D.O. followed by specialist training as a resident in ...
The Post also pointed to debate over puberty blockers in Europe, with "[m]ultiple European health authorities" reviewing scientific evidence for puberty blocker use in minors and "conclud[ing ...